Repositioning Candidates
Repositioning candidates for NAFLD are derived from DrugBank which fall into three categories: therapeutic strategy-associated, target-associated, and indication-associated candidates. For each candidate, detailed properties are extracted from DrugBank, and related strategies, target and NAFLD-associated disease in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
1608 records.
| Candidate ID | Source ID | Source Type | Compound Type | Candidate Name | Inclusion Criteria | |
|---|---|---|---|---|---|---|
| R0201 | DB00584 | approved; vet_approved | small molecule | Enalapril | Therapeutic strategy associated | Details |
| R0202 | DB00586 | approved; vet_approved | small molecule | Diclofenac | Therapeutic strategy associated | Details |
| R0203 | DB00587 | experimental | small molecule | Cinalukast | Therapeutic strategy associated | Details |
| R0204 | DB00590 | approved | small molecule | Doxazosin | Therapeutic strategy associated | Details |
| R0205 | DB00591 | approved; investigational; vet_approved | small molecule | Fluocinolone acetonide | Therapeutic strategy associated | Details |
| R0206 | DB00594 | approved | small molecule | Amiloride | Therapeutic strategy associated | Details |
| R0207 | DB00595 | approved; investigational; vet_approved | small molecule | Oxytetracycline | Indication associated | Details |
| R0208 | DB00596 | approved | small molecule | Ulobetasol | Therapeutic strategy associated | Details |
| R0209 | DB00598 | approved | small molecule | Labetalol | Therapeutic strategy associated | Details |
| R0210 | DB00601 | approved; investigational | small molecule | Linezolid | Indication associated | Details |
| R0211 | DB00603 | approved; investigational | small molecule | Medroxyprogesterone acetate | Therapeutic strategy associated | Details |
| R0212 | DB00605 | approved; investigational | small molecule | Sulindac | Therapeutic strategy associated | Details |
| R0213 | DB00606 | approved | small molecule | Cyclothiazide | Indication associated | Details |
| R0214 | DB00608 | approved; investigational; vet_approved | small molecule | Chloroquine | Target associated | Details |
| R0215 | DB00612 | approved | small molecule | Bisoprolol | Indication associated | Details |
| R0216 | DB00613 | approved; investigational | small molecule | Amodiaquine | Therapeutic strategy associated | Details |
| R0217 | DB00618 | approved | small molecule | Demeclocycline | Indication associated | Details |
| R0218 | DB00619 | approved | small molecule | Imatinib | Therapeutic strategy associated | Details |
| R0219 | DB00620 | approved; vet_approved | small molecule | Triamcinolone | Therapeutic strategy associated | Details |
| R0220 | DB00621 | approved; investigational | small molecule | Oxandrolone | Therapeutic strategy associated | Details |
| R0221 | DB00622 | approved; investigational | small molecule | Nicardipine | Indication associated | Details |
| R0222 | DB00626 | approved; vet_approved | small molecule | Bacitracin | Indication associated | Details |
| R0223 | DB00630 | approved | small molecule | Alendronic acid | Therapeutic strategy associated | Details |
| R0224 | DB00631 | approved; investigational | small molecule | Clofarabine | Therapeutic strategy associated | Details |
| R0225 | DB00635 | approved; vet_approved | small molecule | Prednisone | Therapeutic strategy associated | Details |
| R0226 | DB00636 | approved; investigational | small molecule | Clofibrate | Target associated | Details |
| R0227 | DB00641 | approved | small molecule | Simvastatin | Therapeutic strategy associated | Details |
| R0228 | DB00650 | approved | small molecule | Leucovorin | Indication associated | Details |
| R0229 | DB00654 | approved; investigational | small molecule | Latanoprost | Indication associated | Details |
| R0230 | DB00657 | approved; investigational | small molecule | Mecamylamine | Therapeutic strategy associated | Details |
| R0231 | DB00661 | approved | small molecule | Verapamil | Therapeutic strategy associated | Details |
| R0232 | DB00663 | approved; vet_approved | small molecule | Flumethasone | Therapeutic strategy associated | Details |
| R0233 | DB00668 | approved; vet_approved | small molecule | Epinephrine | Target associated | Details |
| R0234 | DB00669 | approved; investigational | small molecule | Sumatriptan | Therapeutic strategy associated | Details |
| R0235 | DB00671 | approved; investigational | small molecule | Cefixime | Indication associated | Details |
| R0236 | DB00675 | approved | small molecule | Tamoxifen | Therapeutic strategy associated | Details |
| R0237 | DB00682 | approved | small molecule | Warfarin | Therapeutic strategy associated | Details |
| R0238 | DB00684 | approved; investigational | small molecule | Tobramycin | Indication associated | Details |
| R0239 | DB00688 | approved; investigational | small molecule | Mycophenolate mofetil | Therapeutic strategy associated | Details |
| R0240 | DB00691 | approved | small molecule | Moexipril | Indication associated | Details |
| R0241 | DB00692 | approved | small molecule | Phentolamine | Indication associated | Details |
| R0242 | DB00693 | approved | small molecule | Fluorescein | Therapeutic strategy associated | Details |
| R0243 | DB00694 | approved | small molecule | Daunorubicin | Therapeutic strategy associated | Details |
| R0244 | DB00695 | approved; vet_approved | small molecule | Furosemide | Indication associated | Details |
| R0245 | DB00696 | approved | small molecule | Ergotamine | Therapeutic strategy associated | Details |
| R0246 | DB00699 | approved; investigational | small molecule | Nicergoline | Therapeutic strategy associated | Details |
| R0247 | DB00700 | approved | small molecule | Eplerenone | Indication associated | Details |
| R0248 | DB00702 | approved; investigational | small molecule | Icodextrin | Indication associated | Details |
| R0249 | DB00710 | approved; investigational | small molecule | Ibandronate | Therapeutic strategy associated | Details |
| R0250 | DB00712 | approved; investigational | small molecule | Flurbiprofen | Therapeutic strategy associated | Details |
| R0251 | DB00715 | approved; investigational | small molecule | Paroxetine | Indication associated | Details |
| R0252 | DB00716 | approved; investigational | small molecule | Nedocromil | Therapeutic strategy associated | Details |
| R0253 | DB00717 | approved | small molecule | Norethisterone | Indication associated | Details |
| R0254 | DB00724 | approved; investigational | small molecule | Imiquimod | Therapeutic strategy associated | Details |
| R0255 | DB00726 | approved | small molecule | Trimipramine | Indication associated | Details |
| R0256 | DB00727 | approved; investigational | small molecule | Nitroglycerin | Indication associated | Details |
| R0257 | DB00731 | approved; investigational | small molecule | Nateglinide | Target associated | Details |
| R0258 | DB00734 | approved; investigational | small molecule | Risperidone | Indication associated | Details |
| R0259 | DB00738 | approved; investigational | small molecule | Pentamidine | Indication associated | Details |
| R0260 | DB00739 | approved; vet_approved; withdrawn | small molecule | Hetacillin | Indication associated | Details |
| R0261 | DB00741 | approved; vet_approved | small molecule | Hydrocortisone | Therapeutic strategy associated | Details |
| R0262 | DB00742 | approved; investigational | small molecule | Mannitol | Therapeutic strategy associated | Details |
| R0263 | DB00744 | approved; investigational; withdrawn | small molecule | Zileuton | Therapeutic strategy associated | Details |
| R0264 | DB00749 | approved; investigational; vet_approved | small molecule | Etodolac | Therapeutic strategy associated | Details |
| R0265 | DB00751 | approved; investigational | small molecule | Epinastine | Therapeutic strategy associated | Details |
| R0266 | DB00758 | approved | small molecule | Clopidogrel | Therapeutic strategy associated | Details |
| R0267 | DB00759 | approved; vet_approved | small molecule | Tetracycline | Indication associated | Details |
| R0268 | DB00760 | approved; investigational | small molecule | Meropenem | Indication associated | Details |
| R0269 | DB00762 | approved; investigational | small molecule | Irinotecan | Therapeutic strategy associated | Details |
| R0270 | DB00764 | experimental | small molecule | Mometasone | Therapeutic strategy associated | Details |
| R0271 | DB00765 | approved | small molecule | Metyrosine | Therapeutic strategy associated | Details |
| R0272 | DB00768 | approved | small molecule | Olopatadine | Therapeutic strategy associated | Details |
| R0273 | DB00769 | approved | small molecule | Hydrocortamate | Therapeutic strategy associated | Details |
| R0274 | DB00771 | approved | small molecule | Clidinium | Indication associated | Details |
| R0275 | DB00773 | approved | small molecule | Etoposide | Therapeutic strategy associated | Details |
| R0276 | DB00774 | approved; investigational; withdrawn | small molecule | Hydroflumethiazide | Indication associated | Details |
| R0277 | DB00775 | approved | small molecule | Tirofiban | Therapeutic strategy associated | Details |
| R0278 | DB00780 | approved | small molecule | Phenelzine | Indication associated | Details |
| R0279 | DB00784 | approved | small molecule | Mefenamic acid | Therapeutic strategy associated | Details |
| R0280 | DB00785 | approved | small molecule | Cryptenamine | Therapeutic strategy associated | Details |
| R0281 | DB00788 | approved; vet_approved | small molecule | Naproxen | Therapeutic strategy associated | Details |
| R0282 | DB00795 | approved | small molecule | Sulfasalazine | Therapeutic strategy associated | Details |
| R0283 | DB00796 | approved | small molecule | Candesartan cilexetil | Target associated | Details |
| R0284 | DB00800 | approved | small molecule | Fenoldopam | Indication associated | Details |
| R0285 | DB00803 | approved | small molecule | Colistin | Therapeutic strategy associated | Details |
| R0286 | DB00804 | approved | small molecule | Dicyclomine | Indication associated | Details |
| R0287 | DB00805 | approved | small molecule | Minaprine | Indication associated | Details |
| R0288 | DB00808 | approved | small molecule | Indapamide | Therapeutic strategy associated | Details |
| R0289 | DB00811 | approved | small molecule | Ribavirin | Therapeutic strategy associated | Details |
| R0290 | DB00812 | approved; vet_approved | small molecule | Phenylbutazone | Therapeutic strategy associated | Details |
| R0291 | DB00814 | approved; vet_approved | small molecule | Meloxicam | Therapeutic strategy associated | Details |
| R0292 | DB00817 | approved; investigational | small molecule | Rosoxacin | Indication associated | Details |
| R0293 | DB00820 | approved; investigational | small molecule | Tadalafil | Therapeutic strategy associated | Details |
| R0294 | DB00821 | approved; vet_approved; withdrawn | small molecule | Carprofen | Therapeutic strategy associated | Details |
| R0295 | DB00824 | approved; experimental | small molecule | Enprofylline | Indication associated | Details |
| R0296 | DB00827 | approved; investigational; withdrawn | small molecule | Cinoxacin | Indication associated | Details |
| R0297 | DB00828 | approved | small molecule | Fosfomycin | Therapeutic strategy associated | Details |
| R0298 | DB00830 | approved; illicit | small molecule | Phenmetrazine | Indication associated | Details |
| R0299 | DB00833 | approved | small molecule | Cefaclor | Indication associated | Details |
| R0300 | DB00834 | approved; investigational | small molecule | Mifepristone | Indication associated | Details |